国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
1期
73-75
,共3页
刘卫明%梁桥安%金同新%孙妙艳%李宗泉%廖启伟%林耀国
劉衛明%樑橋安%金同新%孫妙豔%李宗泉%廖啟偉%林耀國
류위명%량교안%금동신%손묘염%리종천%료계위%림요국
七叶皂苷钠%甘露醇%脑水肿
七葉皂苷鈉%甘露醇%腦水腫
칠협조감납%감로순%뇌수종
Sodium aescinate%Mannitol%Brain edema
目的 分析七叶皂苷钠联合甘露醇治疗脑水肿的临床疗效.方法 收集从2010年1月到2013年1月收治的220例脑水肿患者临床资料,随机分为对照组与观察组各110例.对照组单纯采取甘露醇治疗,观察组给予七叶皂苷钠联合甘露醇治疗,分析两组患者的临床疗效.结果 观察组患者治疗总有效率为93.64%,明显高于对照组的89.09%,两组比较差异有统计学意义(P<0.05).两组患者不良反应发生率比较差异有统计学意义(P<0.05).结论 七叶皂苷钠联合甘露醇治疗脑水肿,安全性与有效性显著,值得临床推广.
目的 分析七葉皂苷鈉聯閤甘露醇治療腦水腫的臨床療效.方法 收集從2010年1月到2013年1月收治的220例腦水腫患者臨床資料,隨機分為對照組與觀察組各110例.對照組單純採取甘露醇治療,觀察組給予七葉皂苷鈉聯閤甘露醇治療,分析兩組患者的臨床療效.結果 觀察組患者治療總有效率為93.64%,明顯高于對照組的89.09%,兩組比較差異有統計學意義(P<0.05).兩組患者不良反應髮生率比較差異有統計學意義(P<0.05).結論 七葉皂苷鈉聯閤甘露醇治療腦水腫,安全性與有效性顯著,值得臨床推廣.
목적 분석칠협조감납연합감로순치료뇌수종적림상료효.방법 수집종2010년1월도2013년1월수치적220례뇌수종환자림상자료,수궤분위대조조여관찰조각110례.대조조단순채취감로순치료,관찰조급여칠협조감납연합감로순치료,분석량조환자적림상료효.결과 관찰조환자치료총유효솔위93.64%,명현고우대조조적89.09%,량조비교차이유통계학의의(P<0.05).량조환자불량반응발생솔비교차이유통계학의의(P<0.05).결론 칠협조감납연합감로순치료뇌수종,안전성여유효성현저,치득림상추엄.
Objective To explore the therapeutic effect and safety of sodium aescinate combined with mannitol to patients with cerebral edema.Methods 220 patients suffering from cerebral edema form Jan 2010 to Jan 2013 in our hospital were randomly divided into treatment group and control group,with 110 patients in each group.The patients in the control group were treated with mannitol,while sodium aescinate was added to the patients of the treatment group.We compared the clinical efficacy between the two groups.Results The total effective rate in the observation group (93.64%) was significantly higher than that of the control group (89.09%).The incidence of adverse reactions in the two groups had statistical significant difference (P < 0.05).Conclusion Sodium aescinate combined with mannitol in treatment of cerebral edema is safe and effective,worthy of clinical popularization and application.